Understanding Clinical Trial Design - Research Advocacy Network
Understanding Clinical Trial Design - Research Advocacy Network
Understanding Clinical Trial Design - Research Advocacy Network
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
46<br />
UNDERSTANDING CLINICAL TRIAL DESIGN: A TUTORIAL FOR RESEARCH ADVOCATES<br />
Pivotal <strong>Trial</strong> A controlled trial to evaluate the safety and efficacy of a<br />
drug in patients who have the disease or condition to be<br />
treated.<br />
Placebo An inactive substance or treatment that looks the same<br />
as, and is given the same way as, an active drug or<br />
treatment being tested. The effects of the active drug or<br />
treatment are compared to the effects of the placebo.<br />
Population The entire collection of people (current and future) who<br />
are the focus of interest (e.g., all people with a specific<br />
type of cancer).<br />
Population A value of some quantitative characteristic in a<br />
Parameter population. Population parameters are estimated by<br />
sample statistics calculated from sample data (e.g.,<br />
sample mean).<br />
Posterior Probability The posterior probability is the conditional probability<br />
of a variable, taking the evidence into account. The<br />
posterior probability is computed from the prior<br />
probability and the likelihood function via Bayes’<br />
theorem.<br />
Power Power is the probability of rejecting the null hypothesis<br />
if it is really false. It is mathematically equal to 1 - b and<br />
is dependent upon the sample size, sample variance, the<br />
effect size and type II error rate.<br />
Prevalence The total number of existing cases of a disorder as a pro<br />
portion of a population (usually per 100,000 people) at<br />
a specific time.<br />
Primary Endpoint The main result that is measured to see if a given<br />
treatment worked (e.g., the number of deaths or the<br />
difference in survival between the treatment group and<br />
the control group). The primary endpoint is determined<br />
by the primary study objective, and is defined prior to<br />
the start of the trial.<br />
Prior Probability A prior probability is a base rate, interpreted as a<br />
description of what is known about a variable in the<br />
absence of some evidence.<br />
Probability The likelihood that a given event will occur. Probability<br />
is expressed as values between 0 (complete certainty that<br />
an event will not occur) to 1 (complete certainty that an<br />
event will occur), or percentage values between 0 and<br />
100%.